Mixed phenotype acute leukemia with t(9;22) is a rare disease with poor prognosis, and information on optimal treatment is limited. We describe a case where our patient experienced positive outcome after nonacute myeloid leukemia-type intensive induction therapy followed by postremission therapy with stem cell transplant.
Keywords: Acute myeloid leukemia; Philadelphia chromosome; allogeneic stem cell transplantation; de novo acute myeloid leukemia; leukemia in central nervous system; mixed phenotype acute leukemia; tyrosine kinase inhibitor.